Targets › PBPS
1 program from 1 company in 1 trial: 1 Phase 4; Cardiovascular; next expected readout Jul 2027.
Open in Phaseline: the race on PBPS, likelihood bands and readouts
| Company | Drug | Targets | Highest phase | Conditions | Next expected readout |
|---|---|---|---|---|---|
| Fundación Pública Andaluza para la gestión de la Investigación en Sevilla | Ampicillin Bacterial penicillin-binding protein inhibitor | PBPS | Phase 4 | Endocarditis, Infective | Jul 2027 |
Endocarditis, Infective (1)
small molecule (1)
Fundación Pública Andaluza para la gestión de la Investigación en Sevilla (1)
–
Programs group each company's trials by drug; targets and mechanisms come from Open Targets and ChEMBL via Open Targets; expected readouts are Phaseline's estimate from the registry's primary completion date. Facts from the registries only; the approval likelihood is in the app.